ES2069536T3 - Analogos del activador del plasminogeno tisular que tienen dominios modificados del factor de crecimiento. - Google Patents

Analogos del activador del plasminogeno tisular que tienen dominios modificados del factor de crecimiento.

Info

Publication number
ES2069536T3
ES2069536T3 ES88108951T ES88108951T ES2069536T3 ES 2069536 T3 ES2069536 T3 ES 2069536T3 ES 88108951 T ES88108951 T ES 88108951T ES 88108951 T ES88108951 T ES 88108951T ES 2069536 T3 ES2069536 T3 ES 2069536T3
Authority
ES
Spain
Prior art keywords
growth factor
plasminogen activator
tissue plasminogen
analogs
modified growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88108951T
Other languages
English (en)
Inventor
Eileen R Mulvihill
Patrick J O'hara
Bjorn A Nexo
Shinji Yoshitake
Yasunori Ikeda
Suguru Suzuki
Akira Hashimoto
Teruaki Yuzuriha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Eisai Co Ltd
Zymogenetics Inc
Original Assignee
Novo Nordisk AS
Eisai Co Ltd
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS, Eisai Co Ltd, Zymogenetics Inc filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of ES2069536T3 publication Critical patent/ES2069536T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Semiconductor Integrated Circuits (AREA)

Abstract

LA INVENCION SE REFIERE A ANALOGOS DE T-PA QUE CONTIENEN EL DOMINIO DE CRECIMIENTO DEL T-PA NATIVO, TENIENDO EL DOMINIO POR LO MENOS UN RESIDUO DE CISTEINA REEMPLEZADO CON OTRO AMINOACIDO. LOS ANALOGOS DE T-PA PUEDEN CONTENER ADEMAS UNA VARIEDAD DE SUSTITUICIONES Y/O MODIFICACIONES. LAS COMPOSICIONES FARMACEUTICAS CONTIENEN UNO O MAS ANALGOS DE T-PA JUNTO CON UN VEHICULO O DILUYENTE FISIOLOGICAMENTE ACEPTABLE.
ES88108951T 1987-06-04 1988-06-03 Analogos del activador del plasminogeno tisular que tienen dominios modificados del factor de crecimiento. Expired - Lifetime ES2069536T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5806187A 1987-06-04 1987-06-04
US16284788A 1988-03-02 1988-03-02

Publications (1)

Publication Number Publication Date
ES2069536T3 true ES2069536T3 (es) 1995-05-16

Family

ID=26737188

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88108951T Expired - Lifetime ES2069536T3 (es) 1987-06-04 1988-06-03 Analogos del activador del plasminogeno tisular que tienen dominios modificados del factor de crecimiento.

Country Status (14)

Country Link
US (1) US5403734A (es)
EP (1) EP0293936B1 (es)
JP (1) JPS6485079A (es)
KR (1) KR0135427B1 (es)
AT (1) ATE118815T1 (es)
AU (1) AU625752B2 (es)
CA (1) CA1341446C (es)
DE (1) DE3853100T2 (es)
DK (1) DK302388A (es)
ES (1) ES2069536T3 (es)
FI (1) FI101306B1 (es)
IE (1) IE67036B1 (es)
NO (1) NO179874C (es)
NZ (1) NZ224914A (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714372A (en) * 1985-04-22 1998-02-03 Genentech, Inc. Tissue plasminogen activator variants
US5756093A (en) * 1985-04-22 1998-05-26 Genentech, Inc. Tissue plasminogen activator variants
US5736134A (en) * 1985-04-22 1998-04-07 Genentech, In.C Tissue plasminogen activator variants
EP0293934B1 (en) * 1987-06-04 1994-08-31 Zymogenetics, Inc. Mutant t-PA with kringle replacement
GB8815135D0 (en) * 1988-06-24 1988-08-03 British Bio Technology Proteins & nucleic acids
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5258180A (en) * 1988-09-02 1993-11-02 Genetech, Inc. Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5087572A (en) * 1989-12-01 1992-02-11 Genentech, Inc. Dna encoding human plasminogen modified at the cleavage site
US5190756A (en) * 1989-12-01 1993-03-02 Genentech, Inc. Methods and materials for expression of human plasminogen variant
JPH0595786A (ja) * 1991-10-07 1993-04-20 Green Cross Corp:The 変異ヒトプロウロキナーゼ
JP3559559B2 (ja) * 1992-06-03 2004-09-02 ジェネンテク，インコーポレイテッド 向上した治療特性を有する組織プラスミノーゲン活性化因子グリコシル化変異体
US6706504B1 (en) 1996-11-12 2004-03-16 The Scripps Research Institute Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
EP2600891B1 (en) * 2010-08-05 2018-01-17 Council of Scientific & Industrial Research Protein fusion constructs possessing thrombolytic and anticoagulant properties

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79202B (es) * 1982-05-05 1984-10-22 Genentech Inc
WO1984001786A1 (en) * 1982-10-28 1984-05-10 Beecham Group Plc Enzyme derivatives and their use in the treatment of thrombosis
NZ215660A (en) * 1985-04-04 1990-03-27 Beecham Group Plc Tissue plasminogen activator modified in the growth factor domain
DE3682104D1 (de) * 1985-04-22 1991-11-28 Genentech Inc Plasminogenaktivator-mutante des menschlichen gewebes, verfahren und zwischenprodukte dafuer und diese mutante verwendende zusammensetzungen.
US4916071A (en) * 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator
EP0293394B2 (en) * 1986-01-31 2003-10-29 Genetics Institute, LLC Novel thrombolytic proteins
GB2200640B (en) * 1987-01-30 1991-07-10 American Home Prod Des-epidermal growth factor plasminogen activators

Also Published As

Publication number Publication date
US5403734A (en) 1995-04-04
EP0293936B1 (en) 1995-02-22
NO179874B (no) 1996-09-23
JPH0448434B2 (es) 1992-08-06
FI101306B (fi) 1998-05-29
IE67036B1 (en) 1996-05-15
NO179874C (no) 1997-01-02
CA1341446C (en) 2003-11-18
JPS6485079A (en) 1989-03-30
AU1743088A (en) 1988-12-08
DK302388D0 (da) 1988-06-03
FI882627A0 (fi) 1988-06-03
NZ224914A (en) 1991-02-26
IE881680L (en) 1988-12-04
FI101306B1 (fi) 1998-05-29
EP0293936A2 (en) 1988-12-07
DK302388A (da) 1989-02-03
NO882454L (no) 1988-12-05
DE3853100D1 (de) 1995-03-30
KR0135427B1 (ko) 1998-04-23
ATE118815T1 (de) 1995-03-15
AU625752B2 (en) 1992-07-16
EP0293936A3 (en) 1989-09-20
FI882627A (fi) 1988-12-05
KR890000521A (ko) 1989-03-15
NO882454D0 (no) 1988-06-03
DE3853100T2 (de) 1995-08-03

Similar Documents

Publication Publication Date Title
ES2069536T3 (es) Analogos del activador del plasminogeno tisular que tienen dominios modificados del factor de crecimiento.
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
NO882453D0 (no) T-pa-analog.
ATE113846T1 (de) Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.
BR9106330A (pt) Tiofeno sulfonamidas uteis como inibidores da anidrase carbonica
ES2128277T3 (es) Nuevos derivados de peptidos.
EA200201271A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
ES2086436T3 (es) Nuevos eteres y tioeteres de piperidilo inhibidores de la biosintesis de colesterol.
DE69024382D1 (de) Fledermausspeichel-Plasminogenaktivator vPA-alpha 1
ATE103178T1 (de) T-pa pro stabilisierung.
EA200400709A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 293936

Country of ref document: ES